跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,522 条关于
“ALK-Abell”
全部
5,522
临床试验
4,182
药物
489
机构
78
资讯
773
9个月前
Allegria Therapeutics Raises $5.1 Million to Advance Mast Cell-Targeted Therapies for Allergic Diseases
去年
ARS Pharmaceuticals Reports Strong Q3 2025 Growth for Needle-Free Epinephrine Nasal Spray neffy
去年
ARS Pharmaceuticals продвигает Neffy для лечения анафилаксии и расширяет глобальное партнерство
去年
FDA Approves ALK's AccuTest Allergy Skin Testing Devices
去年
NICE Approves First-in-Class Birch Pollen Immunotherapy for Severe Hayfever on NHS
去年
NICE Approves Novel Sublingual Tablet for Severe Dust Mite Allergy Treatment on NHS
去年
ARS Pharmaceuticals' Neffy® Filed for Approval in China, Japan, and Australia
去年
Changchun High-Tech Secures €177.7 Million Deal for ALK's House Dust Mite Allergy Immunotherapies in China
10天前
Allergic Rhinoconjunctivitis Market Set for Evolution Through 2036 as Immunotherapy Access Expands
去年
Peanut Allergy Treatment Market Poised for 16% Growth as New Therapies Enter Pipeline
第 1 页,共 78 页
上一页
下一页